C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 115 filers reported holding C4 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $63,748 | -45.7% | 20,302 | +2.0% | 0.00% | -100.0% |
| Q4 2022 | $117,392 | -32.9% | 19,897 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $175,000 | +18.2% | 19,970 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $148,000 | -68.2% | 19,688 | +2.6% | 0.00% | -66.7% |
| Q1 2022 | $465,000 | -29.7% | 19,181 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $661,000 | -30.1% | 20,532 | -2.9% | 0.00% | -40.0% |
| Q3 2021 | $945,000 | +29.5% | 21,146 | +9.6% | 0.01% | +150.0% |
| Q2 2021 | $730,000 | +217.4% | 19,297 | +210.2% | 0.00% | +100.0% |
| Q1 2021 | $230,000 | +11.7% | 6,220 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $206,000 | – | 6,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |